← Back

Zhejiang Int'L Group Co Ltd

Zhejiang Int'l Group Co., Ltd. is engaged in the wholesale and retail of pharmaceuticals and medical devices in China. It offers chemical drugs, biological products, and traditional Chinese medicine. The company was founded in 1950 and is headquartered in Hangzhou, China.

Country
Price · split & dividend adjusted
News & notes moving 000411.CS
000411.CS2

Intech Group's 2026 interim net profit was 195 million yuan, down 21.45% year on year

Intech Group released its 2026 interim report. Total operating revenue was 17.153 billion yuan, up 3.15% year on year. Net profit attributable to the parent company was 195 million yuan, down 21.45% year on year. Net cash flow from operating activities was negative 295 million yuan, an increase of 404 million yuan compared with the same period last year. The asset-liability ratio was 64.42%, gross margin was 6.70%, return on equity was 3.54%, and diluted earnings per share was 0.35 yuan, down 27.08% year on year. Total asset turnover was 1.00 times, and inventory turnover was 3.73 times. The number of shareholders was 24,700, and the top ten shareholders held 70.23% of the total share capital.
Jiemian·24dRead more →
000411.CS

Inte Group first-half net profit 195 million yuan, down 21.45% year on year

Inte Group disclosed its 2026 half-year report. In the first half, it achieved operating revenue of 17.153 billion yuan, up 3.15% year on year. Net profit attributable to shareholders of the listed company was 195 million yuan, down 21.45% year on year. Basic earnings per share were 0.35 yuan.
证券时报·25dRead more →